Omeprazole Zentiva (Omeprazole)

Omeprazole Zentiva belongs to the proton pump inhibitor class and is used to manage disorders driven by excess gastric acid.

• Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• Erosive gastritis: aids mucosal healing by suppressing acid output.
• NSA‑induced ulcer prophylaxis: lowers the incidence of ulcer formation in patients taking non‑steroidal anti‑inflammatory drugs.

• Omeprazole selectively and irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, allowing the gastrointestinal mucosa to heal and maintain a higher gastric pH.

Omeprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Headache: mild, transient headache reported in clinical use.
• Diarrhoea: loose stools occurring during early treatment.
• Constipation: reduced bowel movements in some patients.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach region.
• Flatulence: increased intestinal gas.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis linked to altered gut flora.
• Osteoporotic fractures: increased risk of hip, wrist or spine fractures with long‑term use.
• Acute interstitial nephritis: sudden kidney inflammation.
• Severe cutaneous adverse reactions: such as Stevens‑Johnson syndrome.
• Hypomagnesemia: low magnesium levels with prolonged therapy.
• Vitamin B12 deficiency: reduced absorption with chronic use.

When prescribing Omeprazole Zentiva, clinicians should consider several safety aspects.

• Assess renal function: adjust use in severe renal impairment.
• Review concomitant medications: potential for altered drug levels.
• Monitor long‑term therapy: evaluate need for continued treatment after several months.
• Pregnancy and lactation: use only if benefit outweighs potential risk.
• Elderly patients: start at lowest effective dose and monitor for fractures.
• Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk.
• Atazanavir and other protease inhibitors: markedly decreased antiviral exposure.
• Methotrexate (high dose): increased serum concentrations, risk of toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, require more frequent monitoring.
• Digoxin: modest rise in serum levels, watch for signs of toxicity.
• Diazepam: increased sedation, adjust dose if needed.